Loading...
XNYS
GLpD
Market cap13bUSD
Jul 09, Last price  
15.26USD
1D
0.79%
1Q
-6.27%
Name

Globe Life Inc

Chart & Performance

D1W1MN
XNYS:GLpD chart
P/E
1.02
P/S
0.20
EPS
14.95
Div Yield, %
Shrs. gr., 5y
-5.49%
Rev. gr., 5y
4.83%
Revenues
6.00b
+3.82%
3,421,178,0003,486,697,0003,196,236,0003,115,073,0003,367,632,0003,377,401,0003,589,516,0003,494,253,0003,620,353,0003,766,065,0003,934,629,0004,156,000,0004,314,829,0004,527,532,0004,738,555,0005,121,352,0005,226,740,0005,447,533,0005,778,069,0005,998,627,000
Net income
1.16b
+8.44%
518,631,000527,535,000452,259,000404,953,000498,866,000497,161,000529,324,000528,472,000542,939,000527,100,000549,779,0001,454,000,000701,466,000760,790,000731,773,0001,031,114,000894,386,000970,755,0001,070,762,0001,161,155,000
CFO
1.40b
-0.43%
865,587,000849,997,000730,611,000976,113,0001,028,593,000859,464,000942,839,0001,119,280,000864,708,0001,120,050,0001,398,708,0001,429,058,0001,277,647,0001,363,874,0001,476,434,0001,437,680,0001,422,194,0001,482,425,0001,402,440,0001,396,391,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Founded in 1979 and based in McKinney, Texas, Globe Life Inc. (formerly Torchmark Corporation until its name change in August 2019) provides an array of life and supplemental health insurance products, alongside annuities, to lower-to-middle-income households across the United States through its various subsidiaries. The company's operations are divided into four primary segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its product offerings include whole life, term life, and other life insurance options; supplemental health coverage such as Medicare supplement, critical illness, and accident plans; and both single-premium and flexible-premium deferred annuities.
IPO date
Dec 31, 1980
Employees
3,543
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT